Dr. Reddy's Laboratories
Search results
A fully integrated pharma company, Aurobindo Pharma features among the top 2 companies in India in terms of consolidated revenues. Aurobindo exports to over 150 countries across the globe with more than 90% of its revenues derived from international operations.
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients.
Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company...
Aurobindo Pharma became a public company in 1992 and listed its shares on the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and anti-biotics, among others.
6 days ago · Aurobindo Pharma Limited: The company is accelerating its growth trajectory to capitalise on the market opportunities through various strategic initiatives including expanding specialty business, accelerating the biosimilar product development, strengthening the supply chain and scaling operations in the growth markets to boost the business.
3 days ago · Check out why Aurobindo Pharma share price is up today. Get all details on Aurobindo Pharma Ltd.shares news and analysis, Forecasts, Dividend, balance sheet, profit & loss, Quarterly results, annual report information, and more
2 days ago · About Aurobindo Pharma. Aurobindo Pharma Limited, a biopharmaceutical company, engages in the manufacture of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, Puerto Rico, and internationally. The company offers formulation in form of oral solids, liquids, injectables, and vaccines, as well as over-the-counter drugs; and active pharmaceutical ingredients (APIs), biosimilars, biocatalysts, peptides, and hormones targeting key ...
Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others.
Get the latest Aurobindo Pharma Ltd (AUROPHARMA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment...
6 days ago · Aurobindo Pharma is stepping up its focus on biosimilars with a huge line-up of products in investments in capacity creation. The Hyderabad-based firm is adopting a two-pronged approach to ...
